These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9134288)

  • 1. Advertising of therapies for cardiovascular patients.
    Foster MC
    Clin Cardiol; 1997 May; 20(5):506-7. PubMed ID: 9134288
    [No Abstract]   [Full Text] [Related]  

  • 2. External counterpulsation for treatment of chronic stable angina pectoris.
    Tecnologica MAP Suppl; 1999 Oct; ():3-5. PubMed ID: 10848082
    [No Abstract]   [Full Text] [Related]  

  • 3. Food and Drug Administration regulation of tobacco: snatching defeat from the jaws of victory.
    Siegel M
    Tob Control; 2004 Dec; 13(4):439-41. PubMed ID: 15564633
    [No Abstract]   [Full Text] [Related]  

  • 4. The First Amendment and the Food and Drug Administration's regulation of labeling and advertising: three proposed reforms.
    Kahan JS; Shapiro JK
    Food Drug Law J; 2003; 58(3):353-64. PubMed ID: 14626983
    [No Abstract]   [Full Text] [Related]  

  • 5. Who will hear? An examination of the regulation of hearing aids.
    Adams SB
    J Contemp Health Law Policy; 1995; 11(2):505-21. PubMed ID: 10143061
    [No Abstract]   [Full Text] [Related]  

  • 6. Clarification: 510k is premarket notification; it provides no patent or FDA approval.
    Burkhart CG
    J Drugs Dermatol; 2008 Feb; 7(2):105. PubMed ID: 18335644
    [No Abstract]   [Full Text] [Related]  

  • 7. Devices and the food and drug administration.
    Phillips SJ; Phillips RS
    Artif Organs; 2005 May; 29(5):363-5. PubMed ID: 15854210
    [No Abstract]   [Full Text] [Related]  

  • 8. User fees and medical device reviews.
    Lewis C
    FDA Consum; 2003; 37(2):18-9. PubMed ID: 12715765
    [No Abstract]   [Full Text] [Related]  

  • 9. The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
    Leghorn J; Brophy E; Rother P
    Food Drug Law J; 2008; 63(2):391-406. PubMed ID: 18561466
    [No Abstract]   [Full Text] [Related]  

  • 10. The FDA and the spine surgeon.
    Ducker TB
    J Spinal Disord; 1999 Aug; 12(4):277-9. PubMed ID: 10451041
    [No Abstract]   [Full Text] [Related]  

  • 11. United States laws under review.
    Leahey M
    Med Device Technol; 2007; 18(3):44-5. PubMed ID: 17585722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External counterpulsation for treatment of chronic stable angina pectoris.
    Tecnologica MAP Suppl; 1998 May; ():3-5. PubMed ID: 10183367
    [No Abstract]   [Full Text] [Related]  

  • 13. Cosmetic medical devices and their FDA regulation.
    Newburger AE
    Arch Dermatol; 2006 Feb; 142(2):225-8. PubMed ID: 16490851
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA set to tighten guidelines on industry dissemination of information on unapproved uses of medical products.
    Lang L
    Gastroenterology; 2008 Apr; 134(4):905. PubMed ID: 18395067
    [No Abstract]   [Full Text] [Related]  

  • 15. Judicial review of FDA preemption determinations.
    Frost A
    Food Drug Law J; 1999; 54(3):367-88. PubMed ID: 11797704
    [No Abstract]   [Full Text] [Related]  

  • 16. Food and Drug Administration regulation of tobacco products: introduction.
    Shatenstein S
    Tob Control; 2004 Dec; 13(4):438. PubMed ID: 15564632
    [No Abstract]   [Full Text] [Related]  

  • 17. Innovative tools, regulatory bodies, and the creative surgeon.
    Reilly JS
    Arch Otolaryngol Head Neck Surg; 2003 Jun; 129(6):678. PubMed ID: 12810478
    [No Abstract]   [Full Text] [Related]  

  • 18. Two intravascular brachytherapy systems approved by FDA.
    SoRelle R
    Circulation; 2000 Nov; 102(21):E9041-3. PubMed ID: 11185473
    [No Abstract]   [Full Text] [Related]  

  • 19. Understanding physician responsibilities and limitations for drug and device off-label use.
    Sclafani AP
    Facial Plast Surg Clin North Am; 2007 May; 15(2):251-4, viii. PubMed ID: 17544942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.